Several HOPA members and their colleagues recently published a new article looking into the role of an inpatient clinical oncology pharmacy technician program.
In order to measure its potential impact, the retrospective study observed the outcomes in patients discharged from the hematology/oncology or bone marrow transplant units at Indiana University Health between April 1, 2016 and March 31, 2017. The study then compared those outcomes to those between April 1, 2018 and March 31, 2019, the year after expanded technician services were implemented. The study found significant increases in patient satisfaction scores, revenue for the retail pharmacy and the overall capture rate of discharge prescriptions after the implementation of expanded inpatient clinical pharmacy technician services.
The full results of the study are now published in JCO Oncology Practice.
Authors: Austin Wooten, PharmD; John Wright, PharmD; Teresa Thakrar, PharmD; Adri Barron, CSPhT; Meagan Grove, PharmD; Raj Duggal, PharmD; Benjamin J. Lee, PharmD; Jean Doh, PharmD; Pamela Maree Di Tomasso, PharmD, MS; Melanie D. Joe, PharmD, MPA; and Shawn P. Griffin, PharmD
